lotronex- alosetron hydrochloride tablet
prometheus laboratories inc. - alosetron hydrochloride (unii: 2f5r1a46yw) (alosetron - unii:13z9hth115) - alosetron 0.5 mg - lotronex is indicated only for women with severe diarrhea-predominant irritable bowel syndrome (ibs) who have: - chronic ibs symptoms (generally lasting 6 months or longer), - had anatomic or biochemical abnormalities of the gastrointestinal tract excluded, and - not responded adequately to conventional therapy. diarrhea-predominant ibs is severe if it includes diarrhea and one or more of the following: - frequent and severe abdominal pain/discomfort, - frequent bowel urgency or fecal incontinence, - disability or restriction of daily activities due to ibs. because of infrequent but serious gastrointestinal adverse reactions associated with lotronex, the indication is restricted to those patients for whom the benefit-to-risk balance is most favorable. clinical studies have not been performed to adequately confirm the benefits of lotronex in men. lotronex should not be initiated in patients with constipation [see warnings and precautions (5.1)] . lotronex is contraindicated in patients with a history of the f
alosetron hydrochloride tablet, film coated
amneal pharmaceuticals of new york llc - alosetron hydrochloride (unii: 2f5r1a46yw) (alosetron - unii:13z9hth115) - alosetron tablets are indicated only for women with severe diarrhea-predominant irritable bowel syndrome (ibs) who have: - chronic ibs symptoms (generally lasting 6 months or longer), - had anatomic or biochemical abnormalities of the gastrointestinal tract excluded, and - not responded adequately to conventional therapy. diarrhea-predominant ibs is severe if it includes diarrhea and one or more of the following: - frequent and severe abdominal pain/discomfort, - frequent bowel urgency or fecal incontinence, - disability or restriction of daily activities due to ibs. because of infrequent but serious gastrointestinal adverse reactions associated with alosetron tablets, the indication is restricted to those patients for whom the benefit-to-risk balance is most favorable. clinical studies have not been performed to adequately confirm the benefits of alosetron tablets in men. alosetron hydrochloride should not be initiated in patients with constipation [see warnings and precautions (5.1)] . alosetron hydrochlor
apollo®
adama - suspensie concentraat (sc) - clofentezin - insecticide
apollo instant hand sanitizer- alcohol gel
sbu group l.p. dba apollo distributors - alcohol (unii: 3k9958v90m) (alcohol - unii:3k9958v90m) - - hand sanitizer to help decrease bactrerial on the skin, when water, soap & towel are not available. - recommended for repeated use.
apollo pressure-activated safety lancets 1.8mm/26gauge
apollo medical technologies ltd -
apollo pressure-activated safety lancets 1.8mm/28gauge
apollo medical technologies ltd -
apollo pressure-activated safety lancets 2.4mm/21gauge
apollo medical technologies ltd -
apollo pressure-activated safety lancets 2.4mm/23gauge
apollo medical technologies ltd -
apollo safety lancets 2.4mm/21gauge
apollo medical technologies ltd -